Patents by Inventor Waseem Qasim

Waseem Qasim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230021636
    Abstract: As described below, the present invention features genetically modified immune cells having enhanced anti-neoplasia activity, resistance to immune suppression, and decreased risk of eliciting a graft versus host reaction, or a combination thereof. The present invention also features methods for producing and using these modified immune effector cells.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 26, 2023
    Applicants: Beam Therapeutics Inc., UCL BUSINESS LTD.
    Inventors: Jason Michael GEHRKE, Aaron D. EDWARDS, Ryan MURRAY, Waseem QASIM
  • Publication number: 20220154216
    Abstract: The invention relates to a minimal U6 pol III promoter. The invention also concerns a nucleic acid construct comprising the minimal U6 pol III promoter, a vector comprising the minimal U6 pol III promoter, methods involving the minimal U6 pol III promoter, and uses for the minimal U6 pol III promoter.
    Type: Application
    Filed: March 13, 2020
    Publication date: May 19, 2022
    Inventors: Waseem QASIM, Christos GEORGIADIS, Roland PREECE, Soragia Athina GKAZI
  • Publication number: 20200087398
    Abstract: The invention relates to T cell-targeted T cells, and methods employed in their production.
    Type: Application
    Filed: December 22, 2017
    Publication date: March 19, 2020
    Inventors: Waseem Qasim, Ulrike Mock, Jane Rasaiyaah
  • Publication number: 20200087681
    Abstract: The invention relates to therapeutic cells, and methods employed in their production.
    Type: Application
    Filed: December 21, 2017
    Publication date: March 19, 2020
    Inventors: Waseem Qasim, Christos Georgiadis, Roland Preece, Ulrike Mock, Lauren Nickolay